[1] Simon Pernot, Thibault Voron, Geraldine Perkins, Christine Lagorce-Pages, Anne Berger, Julien Taieb.Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015 Oct 28;21(40):11428-38.
[2] Chon HJ, Hyung WJ, Kim C, Park S, Kim JH, Park CH, Ahn JB, Kim H, Chung HC, Rha SY, Noh SH, Jeung HC.Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia. Ann Surg. 2017 May;265(5):946-953.
[3] Nichetti F, Morano F, Fabbri A, de Braud F, Di Bartolomeo M.Bilateral parotid gland metastases from gastric signet-ring cell carcinoma. Tumori. 2018 Dec;104(6):NP10-NP13.
[4] P S Akabah, S Mocan, C Molnar, D Dobru .Importance of optical diagnosis in early gastric cancer: A case report of early gastric signet ring cell carcinoma.Niger J Clin Pract. 2017 Oct;20(10):1342-1345.
[5] Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T.Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer. 2006;9(3):177-84.
[6] Goldstein NS, Long A, Kuan SF, Hart J.Colon signet ring cell adenocarcinoma: immunohistochemical characterization and comparison with gastric and typical colon adenocarcinomas. Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):183-8.
[7] Yuasa Y.Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer. 2003 Aug;3(8):592-600.
[8] Odze RD, Lam AK, Ochiai A and Washington MK: WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer, 2019.
[9] Benedict MA, Lauwers GY, Jain D.Gastric Adenocarcinoma of the Fundic Gland Type: Update and Literature Review. Am J Clin Pathol. 2018 Apr 25;149(6):461-473.
[10] Tadashi Terada.An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases. Int J Clin Exp Pathol. 2013;6(4):613-21. Epub 2013 Mar 15.
[11] Keita Kai, Masaaki Satake, Osamu Tokunaga.Gastric adenocarcinoma of fundic gland type with signet-ring cell carcinoma component: A case report and review of the literature. World J Gastroenterol. 2018 Jul 14;24(26):2915-2920.
[12] Venerito M, Link A, Rokkas T, Malfertheiner P.Review: Gastric cancer-Clinical aspects. Helicobacter. 2019 Sep;24 Suppl 1:e12643.
[13] McDonald SA, Greaves LC, Gutierrez-Gonzalez L, Rodriguez-Justo M, Deheragoda M, Leedham SJ, Taylor RW, Lee CY, Preston SL, Lovell M, Hunt T, Elia G, Oukrif D, Harrison R, Novelli MR, Mitchell I, Stoker DL, Turnbull DM, Jankowski JA, Wright NA. Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells. Gastroenterology. 2008 Feb;134(2):500-10.
[14] Takayasu V, Goto EH, Casagrande MZ, Miranda PGA, Diniz GBF, Monteiro MF, Felipe-Silva A.Bicytopenia and leukoerythroblastosis: a rare initial presentation of signet ring cell gastric adenocarcinoma. Autops Case Rep. 2017 Jun 30;7(2):55-60.
[15] Bostjan Humar, Ryuji Fukuzawa, Vanessa Blair, Anita Dunbier, Helen More, Amanda Charlton, Han Kwang Yang, Woo Ho Kim, Anthony E Reeve, Iain Martin, Parry Guilford.Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. Cancer Res. 2007 Mar 15;67(6):2480-9.
[16] Sherif M Karam, Timothy Straiton, Wail M Hassan, Charles Philippe Leblond.Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells. 2003;21(3):322-36.
[17] Sherif M Karam, Timothy Straiton, Wail M Hassan, Charles Philippe Leblond.Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells. 2003;21(3):322-36.
[18] Kim KM, Park CK. Pathology of endoscopic submucosal dissection; how do we interpret?. Korean J Gastroenterol. 2010 Oct;56(4):214-9.
[19] Wang YK, Pathology of gastric tumors,Gao CF, chief editor of Wang YK.
Digestive system oncology. Beijing: People's military medical press,2012,296-404.
[20] Phalanusitthepha C, Grimes KL, Ikeda H, Sato H, Sato C, Hokierti C, Inoue H.Endoscopic features of early-stage signet-ring-cell carcinoma of the stomach. World J Gastrointest Endosc. 2015 Jun 25;7(7):741-6.
[21] Pokala SK, Zhang C, Chen Z, Gamboa AM, Cristofaro SL, Keilin SA, Cai Q, Willingham FF.Incidence, Survival, and Predictors of Lymph Node Involvement in Early-Stage Gastric Signet Ring Cell Carcinoma in the US. J Gastrointest Surg. 2018 Apr;22(4):569-577.
[22] Yang-Kun Wang, Zhong Chen, Tian Yun, Cong-Yang Li, Bo Jiang, Xue-Xia Lv, Guang-Hui Chu, Su-Nan Wang,Hui Yan, Lei-Feng Shi . human epidermal growth factor receptor 2 expression inmixed gastric carcinoma. World Journal of Gastroenterology,2015, 21(15) :4680-4687 .
[23] Yamagiwa H, Yoshimura H, Onishi T. A clinicopathological study of signet-ring cell carcinomas of the stomach. Gan No Rinsho. 1990 Jan;36(1):45-9.
[24] Tourani M, Habibzadeh M, Karkhah A, Shokri-Shirvani J, Barari L, Nouri HR.Association of TNF-α but not IL-1β levels with the presence of Helicobacter pylori infection increased the risk of peptic ulcer development. Cytokine. 2018 Oct;110:232-236.
[25] Youn Nam S, Park BJ, Nam JH, Ryu KH, Kook MC, Kim J, Lee WK. Association of current Helicobacter pylori infection and metabolic factors with gastric cancer in 35,519 subjects: A cross-sectional study. United European Gastroenterol J. 2019 Mar;7(2):287-296. 35,519
[26] El Khadir M, Alaoui Boukhris S, Benajah DA, Ibrahimi SA, Chbani L, Bouguenouch L, El Rhazi K, El Abkari M, Nejjari C, Mahmoud M, Bennani B.Helicobacter pylori CagA EPIYA-C motifs and gastric diseases in Moroccan patients.Infect Genet Evol. 2018 Dec;66:120-129.
[27] Yang-kun Wang.Gastric tumor pathology[M]//Chun-fang Gao,Yang-kun Wang.Digestive oncology.Beijing:People's Military Medical Publishing House, 2012,296-404.
[28] Marques MS, Melo J, Cavadas B, Mendes N, Pereira L, Carneiro F, Figueiredo C, Leite M.Afadin Downregulation by Helicobacter pylori Induces Epithelial to Mesenchymal Transition in Gastric Cells.Front Microbiol. 2018 Nov 9;9:2712.
[29] Sgambato D, Miranda A, Romano L, Romano M.Gut microbiota and gastric disease.Minerva Gastroenterol Dietol. 2017 Dec;63(4):345-354.
[30] Suzuki H, Mori H.World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. 2018 Mar;53(3):354-361.
[31] Wang YK,Non neoplastic diseases of the stomach [M]//Gao CF, Wang YK. Diagnosis and treatment of digestive system diseases. Beijing: People's military medical press,2015;581-675.
[32] Dhakal M, Dhakal OP, Bhandari D, Gupta A. Gastric xanthelasma: an unusual endoscopic finding. BMJ Case Rep. 2013 Oct 28;2013:bcr2013201017.
[33] Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin B, Zambon A, Barter P, Fruchart JC, Eckel RH; International Atherosclerosis Society; International Chair on Cardiometabolic Risk Working Group on Visceral Obesity. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019 Sep;7(9):715-725.
[34] Hoffmann W.Self-renewal of the gastric epithelium from stem and progenitor cells. Front Biosci (Schol Ed). 2013 Jan 1;5:720-31.